Clinical Trials Browser

Phase 3 × INDUSTRY × Infections × Clear all

NCT06632912 2026-01-23

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Phase 3 Active not recruiting

Infections, Papillomavirus Infections

NCT00481767 2020-11-17

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

Phase 3 Completed

676 enrolled 15 charts

Infections, Papillomavirus Infections